MedPath

Frailty Score Assessment for Elderly Patients Undergoing Cardiac Resynchronization Therapy

Completed
Conditions
Heart Failure
Interventions
Other: Frailty
Registration Number
NCT02369419
Lead Sponsor
Centre Hospitalier Universitaire, Amiens
Brief Summary

Background: The cardiac resynchronization therapy (CRT) has been shown to improve symptoms and outcome of patients with congestive heart failure (HF), and depressed left ventricular ejection fraction (LVEF \< 35 %). The rate of non-responders to CRT is estimated at 30 %. Yet, the impact of frailty on the response to CRT has not been studied, until now.

Purpose : To assess the impact of frailty in the elderly, on the response to CRT.

Detailed Description

Methods : Frailty is evaluated before implant ,and defined as \<14/17 points using the ONCODAGE score, in 150 patients of \> 70 years age, selected for CRT according to the ESC 2013 guidelines. The response to CRT, estimated at 9 months, is defined as an improvement of at least 5 % of the LVEF and the absence of HF hospitalization or cardiovascular death.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
150
Inclusion Criteria
  • Patients of > 70 years age,
  • Selected for CRT according to the ESC 2013 guidelines
Exclusion Criteria
  • patients included in other clinical trial which can interfere with the results of this one

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
CRTFrailtyPatients over 70 years age, selected for CRT according to the ESC 2013 guidelines.
Primary Outcome Measures
NameTimeMethod
non response on CRT9 months
Secondary Outcome Measures
NameTimeMethod
seric albumin9 months

To assess the impact of seric albumin on the response to CRT

seric gammaglutamyltranferase9 months

To assess the impact of seric gammaglutamyltranferase on the response to CRT

mortality9 months

Trial Locations

Locations (1)

CHU; Service de Cardiologie, Rythmologie et Stimulation cardiaque

🇫🇷

Amiens, France

© Copyright 2025. All Rights Reserved by MedPath